Yaser M Alahmadi
Overview
Explore the profile of Yaser M Alahmadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahmoud M, Fadil H, Omer S, Alsehli M, Alsharif R, Alfadly S, et al.
BMC Med Educ
. 2025 Mar;
25(1):381.
PMID: 40082935
Background: Pharmacy students' preparedness to provide pharmaceutical care (PC) is crucial for ensuring optimal patient outcomes. Understanding their self-assessed readiness across different competency areas and identifying barriers can help identify...
2.
Fadil H, Alrehaili Z, Alharbi K, Almuzaini A, Alharbi R, Alharbi H, et al.
Risk Manag Healthc Policy
. 2024 Dec;
17:3227-3238.
PMID: 39717360
Background: The aging global population presents challenges in medication management, particularly among diabetic elderly patients vulnerable to potentially inappropriate medications (PIM). PIM can lead to adverse outcomes like hypoglycemia, falls,...
3.
Ali H, Hanafy A, Bafail R, Alrbyawi H, Almaghrabi M, Alahmadi Y, et al.
Int J Nanomedicine
. 2024 Nov;
19:11819-11846.
PMID: 39558914
Background: Budesonide (BUD) is a BCS class II medication with poor water solubility and limited oral bioavailability. In this study, innovative solid self-microemulsifying drug delivery systems (BUD-SMEDDS) were developed for...
4.
Anwar Bakr R, Kotta S, Aldawsari H, Ashri L, Badr-Eldin S, Eltahir H, et al.
Front Pharmacol
. 2024 Aug;
15:1440361.
PMID: 39156110
Layered double hydroxides (LDHs) are highly effective drug delivery systems, owing to their capacity to intercalate or adsorb biomaterials, flexible structure, swelling property, high stability, good biocompatibility, and ease of...
5.
Eltahir H, Elbadawy H, Almikhlafi M, Alalawi A, Aldhafiri A, Alahmadi Y, et al.
Front Pharmacol
. 2024 Jun;
15:1389670.
PMID: 38910880
Background: Acute pancreatitis (AP) is an inflammatory condition that resolves spontaneously, but occasionally, develops into systemic inflammation, organ failure and mortality. Oxidative stress and activation of inflammatory pathways represent major...
6.
Ali H, Namazi N, Elbadawy H, El-Sayed A, Ahmed S, Bafail R, et al.
Int J Nanomedicine
. 2024 Jan;
19:209-230.
PMID: 38223883
Background: Repaglinide (REP) is an antidiabetic drug with limited oral bioavailability attributable to its low solubility and considerable first-pass hepatic breakdown. This study aimed to develop a biodegradable chitosan-based system...
7.
Ahmed S, Abdallah N, Almaghrabi M, Alahmadi Y
Talanta
. 2023 Dec;
269:125498.
PMID: 38056419
A high-throughput therapeutic monitoring method was developed for repaglinide (RPG) in diabetic patients, combining parallel artificial liquid membrane extraction (PALME) with ultraperformance liquid chromatography electrospray ionization tandem mass spectrometry (UPLC-ESI-MS/MS)....
8.
Alzahrani F, Alahmadi Y, Al Thagfan S, Alolayan S, Elbadawy H
Pharmacy (Basel)
. 2023 Oct;
11(5).
PMID: 37888500
In Saudi Arabia, community pharmacies offer healthcare services for different conditions. However, clarity of the competence of pharmacists in managing migraines is lacking. This study aimed to explore the current...
9.
Abdallah N, Ahmed S, Almaghrabi M, Alahmadi Y
Polymers (Basel)
. 2023 Oct;
15(19).
PMID: 37836040
Current fundamental electrochemical research shows the potential of utilizing polymeric nanostructured materials as ion-to-electron transducers. In this paper, aniline was polymerized in the presence of TiO and CuO nanoparticles to...
10.
Alsehemi A, Alharbi E, Alammash B, Alrais A, Elbadawy H, Alahmadi Y
Saudi Pharm J
. 2023 Jun;
31(6):1084-1093.
PMID: 37293381
Background: Bacterial resistance has become a global health concern. To treat suspected multidrug resistant organisms (MDROs), physicians first use broad-spectrum antibiotics; however, this increases the chance of developing antimicrobial resistance....